{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:23:18Z","timestamp":1791202998650,"version":"4.2.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.amjcard.2013.09.011","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T03:35:20Z","timestamp":1380857720000},"page":"54-59","source":"Crossref","is-referenced-by-count":42,"title":["Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting"],"prefix":"10.1016","volume":"113","author":[{"given":"Mathieu","family":"Pankert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Quilici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson Diendonn\u00e9","family":"Loundou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Verdier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Deharo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Gaborit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Emmanuel","family":"Morange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Val\u00e9ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dutour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cuisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2013.09.011_bib1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","volume":"102","author":"Bertrand","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.09.011_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2013.09.011_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2013.09.011_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2013.09.011_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1160\/TH11-01-0040","article-title":"High platelet reactivity and clinical outcome\u2014fact and fiction","volume":"106","author":"Sibbing","year":"2011","journal-title":"Thromb Hemost"},{"key":"10.1016\/j.amjcard.2013.09.011_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pharmthera.2010.04.017","article-title":"Current strategies in antiplatelet therapy\u2014does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?","volume":"127","author":"Geisler","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2013.09.011_bib7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.amjcard.2009.01.341","article-title":"Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention","volume":"103","author":"Price","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.09.011_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1538-7836.2005.01751.x","article-title":"High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome","volume":"4","author":"Cuisset","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.amjcard.2013.09.011_bib9","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jacc.2007.01.094","article-title":"Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis","volume":"49","author":"Buonamici","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2013.09.011_bib10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1538-7836.2009.03709.x","article-title":"Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement","volume":"8","author":"Sibbing","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.amjcard.2013.09.011_bib11","first-page":"325","article-title":"Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?","volume":"5","author":"Cuisset","year":"2009","journal-title":"Euro Intervention"},{"key":"10.1016\/j.amjcard.2013.09.011_bib12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jcin.2013.04.009","article-title":"Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (Predictor Of Bleedings with Antiplatelet drugs)","volume":"6","author":"Cuisset","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2013.09.011_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.amjcard.2012.08.043","article-title":"Prasugrel monitoring and bleeding in real world patients","volume":"111","author":"Cayla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.09.011_bib14","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jcin.2012.07.015","article-title":"CYP2C19 *2 and *17 alleles have a significant impact on platelet response and bleeding risk in patients treated with prasugrel after acute coronary syndrome","volume":"5","author":"Cuisset","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2013.09.011_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.amjcard.2011.08.034","article-title":"Residual platelet reactivity, bleedings, and adherence to treatment in patients having coronary stent implantation treated with prasugrel","volume":"109","author":"Parodi","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.09.011_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.amjcard.2007.02.081","article-title":"Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of clopidogrel before percutaneous coronary intervention","volume":"100","author":"Sibbing","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.09.011_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.thromres.2008.04.003","article-title":"Relationship between aspirin and clopidogrel responses in acute coronary syndrome and clinical predictors of non response","volume":"123","author":"Cuisset","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2013.09.011_bib18","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2013.09.011_bib19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199910073411501","article-title":"Body-mass index and mortality in a prospective cohort of U.S. adults","volume":"341","author":"Calle","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2013.09.011_bib20","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1000367","article-title":"Body-mass index and mortality among 1.46 million white adults","volume":"363","author":"Berrington de Gonzalez","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2013.09.011_bib21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/s-0037-1614344","article-title":"Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets-definition and detection of ticlopidine\/clopidogrel effects","volume":"82","author":"Schwarz","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2013.09.011_bib22","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.09.011_bib23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"36","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2013.09.011_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jcin.2008.08.018","article-title":"Glycoprotein IIb\/IIIa inhibitors improve outcome after coronary stenting in clopidogrel non-responders: a prospective, randomized study","volume":"1","author":"Cuisset","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2013.09.011_bib25","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1161\/CIRCULATIONAHA.108.833236","volume":"119","author":"Valgimigli","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.09.011_bib26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2013.09.011_bib27","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","volume":"59","author":"Trenk","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2013.09.011_bib28","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2013.09.011_bib29","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1038\/oby.2008.285","article-title":"Monitoring the obesity epidemic in France: the ObEpi surveys 1997\u20132006","volume":"16","author":"Charles","year":"2008","journal-title":"Obesity"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914913019280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914913019280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,28]],"date-time":"2019-07-28T20:55:36Z","timestamp":1564347336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914913019280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0002914913019280"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2013.09.011","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}